News | Treatment Planning | May 02, 2016

Mirada Medical Showcases Latest Radiotherapy Advancements at 35th ESTRO Congress

Company will highlight RTx planning software and Workflow Box for adaptive contouring

Mirada Medical, 35th ESTRO Congress, radiotherapy treatment planning, RTx, Workflow Box

RTx software image courtesy of Mirada Medical

May 2, 2016 — Mirada Medical announced it will showcase its latest solutions for radiotherapy, including RTx and Workflow Box, at the European Society for Radiation Oncology (ESTRO) 2016 Congress, April 29-May 2 in Torino, Italy.

The number and types of images — computed tomography (CT), positron emission tomography (PET) and magnetic resonance imaging (MRI) — used for modern protocols has significantly increased in the past years. This has created the daily challenge of precise and accurate alignment of the different images.

Having recently acquired the Mirada RTx solution for The Christie NHS Foundation Trust in Manchester, U.K., Prof. Marcel Van Herk declared: “We have chosen Mirada as strategic partner to develop multimodality imaging solutions because of the quality of their software, allowing rapid translation of novel techniques into our clinic while also providing the possibility to efficiently integrate workflows for the different treatment techniques that are available at our site.”

Modern protocols such as image-guided radiation therapy (IGRT), stereotactic body radiation therapy (SBRT) or volumetric modulated arc therapy (VMAT) also require thin-slice imaging to precisely target disease and spare healthy tissue, which has created a significant burden in manual contouring. While several vendors have introduced auto-contouring, Mirada is showcasing what it claims is the only zero-click, truly automated multi-atlas contouring solution. The Mirada solution employs unique SMART (Scalable Multi-Atlas for Radiation Therapy) technology and relies on the Mirada image registration engine. It is designed to save time and improve consistency for initial contouring and adaptive re-contouring. Being vendor-agnostic, it also integrates seamlessly into any radiotherapy workflow.

Further, through the course of radiotherapy, patient anatomy may change. In addition, changes in the shape, size and position of targeted disease are likely. It is a daily challenge to assess whether the treatment plan needs to be updated to account for these changes. Mirada RTx turns the complex task of adaptive assessment into a rapid and accurate multi-timepoint comparison of images, structures and doses. With its zero-click SMART contouring solution Workflow Box, Mirada automates the previously laborious task of adaptive re-contouring.

“Technology is a major part of our treatment and workflow improvement strategy. We chose Mirada because their contouring solution allows us the flexibility to push boundaries in research whilst using robust workflows we can trust in a clinical setting as well. With growing patient numbers and treatment complexity, increasing efficiency and flexibility whilst improving quality and precision has become imperative.”  said Peter Remeijer, Ph.D., from Dutch Cancer Institute Antoni Van Leeuwen NKI, Amsterdam.

For more information: www.mirada-medical.com

Related Content

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Professor David Sebag-Montefiore (Image courtesy of the University of Leeds)

Professor David Sebag-Montefiore (Image courtesy of the University of Leeds)

News | Radiation Therapy | April 07, 2020
April 7, 2020 — An intern...
Eclipse v16 has received CE mark and is 510(k) pending
News | Proton Therapy | April 06, 2020
April 6, 2020 — Driven by its Intelligent Cancer Care approach in developing new solutions that use advanced technolo
Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Feature | Treatment Planning | April 03, 2020 | Dave Fornell, Editor
The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new
Women are more likely to be cured of cancer by radiotherapy but the side effects are worse.

Women are more likely to be cured of cancer by radiotherapy but the side effects are worse. Image by Mark Kostich

News | Radiation Therapy | March 30, 2020
March 30, 2020 — Women undergoing radiotherapy for
A new framework from an international team of experts aims to help protect patients and providers, and conserve protective equipment for frontline healthcare workers #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Prostate Cancer | March 30, 2020
March 30, 2020 — In the wake of the COVID-19 pan
Accuray Incorporated announced that Mercy Hospital St. Louis continues to demonstrate its commitment to improving patient outcomes with the installation of the first CyberKnife M6 System in Missouri at their state-of-the-art David C. Pratt Cancer Center
News | Stereotactic Body Radiation Therapy (SBRT) | February 27, 2020
February 27, 2020 — Accuray Incorporated announced that Mercy
Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure

Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure. This picture shows a circle of hydrogel that was irradiated on the left half, which is slightly pink; whereas the right half of the gel is not irradiated and remains colorless.

News | Radiation Therapy | February 18, 2020
February 18, 2020 — More than half of all cancer patients undergo radiation therapy and the dose is critical.
Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
Accuray TomoTherapy total body irradiation
News | Radiation Therapy | February 07, 2020
February 7, 2020 — Accuray Incorporated announced that two new studies demonstrate the benefits of the ...